tirzepatide spray Mounjaro (Tirzepatide) Injection 5 mg/0.5

The largest and longest trial to date includes 320 individuals with biopsy-confirmed NASH and fibrosis randomised to treatment with once-daily semaglutide (0.1 mg, 0.2 mg or 0.4 mg) vs placebo [69]

Tea and health: Studies in humans

[5] Wilding JPH, Batterham RL, Davies M, et al

Preserved incretin activity of glucagon-like peptide 1 7-36 amide but not of synthetic human gastric inhibitory polypeptide in patients with type-2 diabetes mellitus

These recommendations aim to mitigate the risks for patients undergoing procedures requiring anaesthesia or sedation

Tirzepatide activates two important hormone pathways: GLP-1 and GIP